Research Article - (2018) Volume 9, Issue 1
The Use of Concomitant Immunomodulators with Adalimumab Therapy in Pediatric Crohn’s Disease
- Keith J Benkov*, George H Russell, Charles M Samson, Steven J Steiner, Eileen C King, Jesse Pratt, Samantha F Eichner, Richard B Colletti and ImproveCareNow Network
- 1Pediatric Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
- 2Pediatric Gastroenterology, Barbara Bush Children's Hospital, Portland, Maine, United States
- 3Gastroenterology, Hepatology and Nutrition; Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, MO, United States
- 4Pediatric Gastroenterology, Hepatology and Nutrition, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, United States
- 5Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States
- 6Inflammatory Bowel Disease Center, AbbVie, Chicago, IL, United States
- 7Washington University Children's Hospital, Burlington, VT, United States
- 8Additional ImproveCareNow contributing co-authors are listed following the Discussion, United States
*Corresponding Author:
Keith J Benkov, Department of Pediatric Gastroenterology, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, Box 1656, New York, NY 10029, USA, Tel: (212) 241-5415, Fax: (212) 241-1459
Email:
